ProstaRex

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameProstaRex
Drug Alias NameAIT (AltaRex)anti-idiotype induction therapy (Paladin)anti-idiotype induction therapy (United Therapeutics)protate cancer therapy (ViRexx/United Therapeutics)anti-idiotype induction therapy (AltaRex/United Therapeutics) +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProstate-specific antigen inhibitors
TargetsProstate-specific antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltaRex Medical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPaladin Labs IncAltaRex Medical CorpVirexx Medical Corp +[5] 
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A